引用本文: |
-
刘鹏飞,徐雯,刘凯,等.原发性肝癌术后胸腔积液的预防和处理[J].同济大学学报(医学版),2017,38(2):95-97. [点击复制]
- LIU Peng-fei,XU Wen,LIU Kai,et al.Factors related to postoperative pleural effusion in patients with primary liver cancer[J].同济大学学报(医学版),2017,38(2):95-97. [点击复制]
|
|
摘要: |
目的 探讨减少原发性肝癌术后胸腔积液发生率的方法。方法 回顾性分析165例右肝切除术后出现胸腔积液患者肝脏切除量、常温下肝门阻断时间、术后人血白蛋白补充情况对术后胸腔积液的影响。结果 术后右侧胸腔积液超过5cm的比例,右半肝切除高于局部肝脏切除(31.91% vs 7.63%);肝门阻断时间超过15min者明显高于阻断时间不足15min者(26.47% vs 6.19%);术后人血白蛋白补充总量超过50g者明显低于不足50g者(7.58% vs 19.19%)。结论 对于右肝切除的患者应该尽量减少肝脏切除、缩短肝门阻断时间,并在术后尽快补充血白蛋白浓度至正常范围,可以明显减少术后大量胸腔积液的发生。 |
关键词: 原发性肝癌 肝切除 肝门阻断 人血白蛋白 |
DOI:10.16118/j.1008-0392.2017.02.019 |
投稿时间:2016-10-19 |
基金项目: |
|
Factors related to postoperative pleural effusion in patients with primary liver cancer |
LIU Peng-fei,XU Wen,LIU Kai,YE Chun |
(Dept.of Hepatobiliary Surgery, Tongji Hospital, Tongji University, Shanghai 200065, China;Dept.of Radiology, Shanghai Ouyang Hospital, Hongkou Distrist, Shanghai 200081, China) |
Abstract: |
Objective To investigate the factors related to postoperative pleural effusion in patients with primary liver cancer. Methods Clinical data of 165 patients with primary liver cancer undergoing right liver resection were retrospectively reviewed. The relationship of liver resection size, hilar blocking time and postoperative albumin supplementary with pleural effusion was analyzed. ResultsThe incidence of postoperative pleural effusion >5cm, as shown on echography, in patients with right half liver resection was higher than those with local excision(31.91% vs 7.63%), in patients with hilar blocking time >15min was higher than those with blocking time <15min(26.47% vs 6.19%), and in patients with postoperative albumin supplement >50g was lower than those with albumin supplement <50g(7.58% vs 19.19%). Conclusion To decrease the postoperative massive pleural effusion it is suggested to reduce the resection liver size, to shorten hilar blocking time and to supplement sufficient albumin after surgery in patients undergoing right liver resection. |
Key words: primary liver cancer liver resection hilar blocking time human blood albumin |